magnesium sulfate has been researched along with Cerebral Intraventricular Haemorrhage in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beltempo, M; Bertelle, V; Boucorian, I; Dahlgren, L; Lemyre, B; Pelausa, E; Rizzolo, A; Shah, PS; St Hilaire, M | 1 |
| Canpolat, FE; Kutman, HGK; Oğuz, SS; Oğuz, Y; Ozer Bekmez, B; Tayman, C; Uygur, D | 1 |
| Bhutada, A; Brown, A; Egbert, NM; Haberman, S; Minkoff, H; Narasimhulu, D; Rastogi, S; Rojas, M | 1 |
| Ancel, PY; Benhammou, V; d'Ercole, C; Delorme, P; Foix-L'Hélias, L; Gire, C; Goffinet, F; Kayem, G; Lorthe, E; Marchand-Martin, L; Sentilhes, L; Subtil, D; Torchin, H; Winer, N | 1 |
4 other study(ies) available for magnesium sulfate and Cerebral Intraventricular Haemorrhage
| Article | Year |
|---|---|
Cumulative effect of evidence-based practices on outcomes of preterm infants born at <29 weeks' gestational age.
Topics: Adrenal Cortex Hormones; Anticonvulsants; Body Temperature; Canada; Cerebral Intraventricular Hemorrhage; Constriction; Evidence-Based Medicine; Female; Humans; Infant, Extremely Premature; Infant, Newborn; Leukomalacia, Periventricular; Logistic Models; Magnesium Sulfate; Male; Multivariate Analysis; Perinatal Death; Pregnancy; Prenatal Care; Retrospective Studies; Severity of Illness Index; Time Factors; Umbilical Cord | 2020 |
The Effect of Antenatal Neuroprotective Magnesium Sulfate Treatment on Cerebral Oxygenation in Preterm Infants.
Topics: Brain; Cerebral Intraventricular Hemorrhage; Female; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Male; Neuroprotection; Oxygen; Oxygen Saturation; Pregnancy; Premature Birth; Prenatal Care; Prospective Studies; Spectroscopy, Near-Infrared | 2021 |
Maternal magnesium therapy, neonatal serum magnesium concentration and immediate neonatal outcomes.
Topics: Adult; Case-Control Studies; Cerebral Intraventricular Hemorrhage; Dose-Response Relationship, Drug; Female; Gestational Age; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infusions, Intravenous; Leukomalacia, Periventricular; Magnesium; Magnesium Sulfate; Male; Neuroprotective Agents; Pregnancy; Retrospective Studies; Tocolytic Agents; Young Adult | 2017 |
Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2).
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Cerebral Intraventricular Hemorrhage; Cerebral Palsy; Cesarean Section; Child, Preschool; Enterocolitis, Necrotizing; Female; Fetal Membranes, Premature Rupture; Fetal Mortality; Fetal Viability; France; Gestational Age; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Labor, Obstetric; Leukomalacia, Periventricular; Magnesium Sulfate; Patient Transfer; Perinatal Mortality; Pregnancy; Pregnancy Trimester, Second; Prenatal Care; Retinopathy of Prematurity; Stillbirth; Survival Rate; Tocolysis; Tocolytic Agents | 2018 |